Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2014 074 212.2 |
96 | EP file number | EAKZ | 14 74 8185.7 |
86 | WO file number | WAKZ | PCT/EP2014/066650 |
97 | EP publication number | EPN | 3027650 |
87 | WO publication number | WPN | 2015015003 |
54 | Designation/title | TI | ANTIKÖRPER, DIE EINEN KOMPLEX AUS MENSCHLICHEM GLYCOPROTEIN A REPETITIONS PREDOMINANT (GARP) UND LATENT TGF-BETA-1 BINDEN |
51 | IPC main class | ICM (ICMV) | C07K 16/28 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 39/00 (2006.01), A61K 39/395 (2006.01), A61P 35/00 (2006.01), A61P 37/04 (2006.01) |
22 | DE application date | DAT | Aug 1, 2014 |
96 | EP application date | EAT | Aug 1, 2014 |
86 | WO application date | WAT | Aug 1, 2014 |
43 | Date of first publication | OT | Feb 5, 2015 |
| Date of publication of grant | PET | Jan 13, 2021 |
71/73 | Applicant/owner | INH | argenx BV, Gent, BE; Ludwig Institute for Cancer Research Ltd, Zürich, CH; Universite Catholique de Louvain, Louvain-la-Neuve, BE |
72 | Inventor | IN | LUCAS, Sophie, B-3080 Tervuren, BE; COULIE, Pierre, B-1950 Krainem, BE; CUENDE VILLASUR, Julia, B-3060 Bertem, BE; DUMOUTIER, Laure, B-1360 Orbais, BE; RENAULD, Jean-Christophe, B-1950 Kraainem, BE; VAN DER WONING, Sebastian, B-9800 Bachte Maria Leerne, BE; SAUNDERS, Michael, B-1190 Brussel, BE; DE HAARD, Hans, NL-4436NA Oudelande, NL; DE BOECK, Gitte, B-1840 Malderen, BE |
| Address for service | | JAK France, 47000 Agen, FR |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361861008 P Aug 1, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| EP 14167425 May 7, 2014
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| EP 13178958 Aug 1, 2013
|
| Due date | FT FG | Aug 31, 2025 Annual fee for the 12th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003027650 Searchable text:
EP000003027650 Original document:
EP000003027650B1 Searchable text:
EP000003027650B1 Original document:
WO002015015003 Searchable text:
WO002015015003 |
43 | Date of first publication | EVT | Feb 5, 2015 |
| Date of the first transfer into DPMAregister | EREGT | Jul 22, 2016 |
| Date of the (most recent) update in DPMAregister | REGT | Sep 10, 2024 (Show all update days)(Hide all update days)- Sep 10, 2024
- St.36: changed (technical change)
- Jul 13, 2024; May 9, 2024; Jul 14, 2023; Dec 1, 2022; Nov 4, 2022; Oct 26, 2022; Jun 28, 2022; Dec 30, 2021; Nov 25, 2021; Jul 21, 2021; Jan 15, 2021; Dec 29, 2020; Dec 24, 2020; Dec 17, 2020; Jul 16, 2020; Sep 28, 2017; Jun 8, 2017
- Historical data not available for this/these date(s)
- Jul 22, 2016
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 8)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Oct 25, 2022 |
| Issue number | HN | 48 |
| Year | PJ | 2022 |
| Publication date | VT | Dec 1, 2022 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Argenx BV, Gent, BE; Ludwig Institute for Cancer Research Ltd, Zürich, CH; Universite Catholique de Louvain, Louvain-la-Neuve, BE |
71/73 | Previous applicant/owner | INHF | argenx BVBA, Zwijnaarde, BE, Ludwig Institute for Cancer Research Ltd, Zürich, CH, Universite Catholique de Louvain, Louvain-la-Neuve, BE |
| Date of update of the procedure | REGT | Nov 4, 2022 |
View procedures New applicant/owner details (No.: 9)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Nov 3, 2022 |
| Issue number | HN | 50 |
| Year | PJ | 2022 |
| Publication date | VT | Dec 15, 2022 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | argenx BV, Gent, BE; Ludwig Institute for Cancer Research Ltd, Zürich, CH; Universite Catholique de Louvain, Louvain-la-Neuve, BE |
71/73 | Previous applicant/owner | INHF | Argenx BV, Gent, BE, Ludwig Institute for Cancer Research Ltd, Zürich, CH, Universite Catholique de Louvain, Louvain-la-Neuve, BE |
| Date of update of the procedure | REGT | Dec 1, 2022 |